Drugs / ⁶⁸Ga-FC516
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07468708 | Mar → Jul 2026 overdue | prostate cancer | FindCure Biosciences (ZhongShan) Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ⁶⁸Ga-FC516 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07468708 ↗ |
| Modality | Diagnostic / imaging agent | “preliminary diagnostic efficacy” NCT07468708 ↗ |